Michelle Ely Ricardo, MOTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 29099 Hospital Road, 106, Lake Arrowhead, CA 92352 Phone: 909-337-0844 |
Dr. Angela Baker, OTD, PHD, MA,OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 28476 Larchmont Lane, Lake Arrowhead, CA 92385 Phone: 626-826-4049 |
News Archive
Patient safety in the hospital begins with the young doctors during their residency training. With this in mind, SAVE THE PATIENT is hosting a community talk show to highlight the importance of sound resident training practices in our Chicago-land hospitals.
A bill (HR 178) introduced in January by Rep. Barbara Lee (D-Calif.) would require prisons to provide HIV counseling and prevention education efforts and to distribute "sexual barrier protection devices" to inmates in federal prisons, the Oakland Tribune reports.
Researchers at the Perelman School of Medicine at the University of Pennsylvania report in a new study that thickening of the heart's right ventricle is associated with an increased risk of heart failure and cardiovascular death in patients without clinical cardiovascular disease at baseline. The study is published online ahead of print in the journal Circulation.
A number of researchers at the Department of Polymer Science and Technology at the Chemistry Faculty from San Sebastian at the University of the Basque Country, led by Ms Isabel Goni and Ms Marilo Gurrutxaga, are studying new formulae for acrylic copolymers and compounds in order to obtain efficacious, multiuse bone cements with reduced side effects.
A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow the progression of Alzheimer's disease.
› Verified 2 days ago